Literature DB >> 22171576

Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.

Remond J A Fijneman1, Rebecca A Anderson, Ethan Richards, Jieming Liu, Marianne Tijssen, Gerrit A Meijer, Janae Anderson, Annette Rod, Michael G O'Sullivan, Patricia M Scott, Robert T Cormier.   

Abstract

The Runx1 transcription factor plays an important role in tissue homeostasis through its effects on stem/progenitor cell populations and differentiation. The effect of Runx1 on epithelial differentiation of the secretory cell lineage of the colon was recently demonstrated. This study aimed to examine the role of Runx1 in tumor development in epithelial cells of the gastrointestinal tract. Conditional knockout mice that lacked Runx1 expression in epithelial cells of the GI tract were generated. These mice were crossed onto the Apc(Min) background, killed and their intestinal tumor phenotypes were compared with Apc(Min) Runx1 wild-type control mice. Apc-wild-type Runx1-mutant mice were also examined for tumor development. Colons from Runx1 knockout and wild-type mice were used for genome-wide mRNA expression analyses followed by gene-specific quantitative RT-PCR of whole colon and colon epithelium to identify Runx1 target genes. Runx1 deficiency in intestinal epithelial cells significantly enhanced tumorigenesis in Apc(Min) mice. Notably, epithelial Runx1 deficiency in Apc-wild-type mice was sufficient to cause tumor development. Absence of Runx1 was associated with global changes in the expression of genes involved in inflammation and intestinal metabolism, and with gene sets indicative of a metastatic phenotype and poor prognosis. Gene-specific analysis of Runx1-deficient colon epithelium revealed increased expression of genes linked to an expansion of the stem/progenitor cell population. These results identify Runx1 as a novel tumor suppressor gene for gastrointestinal tumors and support a role for Runx1 in maintaining the balance between the intestinal stem/progenitor cell population and epithelial differentiation of the GI tract.
© 2011 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22171576      PMCID: PMC5439111          DOI: 10.1111/j.1349-7006.2011.02189.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  85 in total

1.  Requirement of Math1 for secretory cell lineage commitment in the mouse intestine.

Authors:  Q Yang; N A Bermingham; M J Finegold; H Y Zoghbi
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

2.  Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture.

Authors:  Andrew C Boquest; Aboulghassem Shahdadfar; Katrine Frønsdal; Olafur Sigurjonsson; Siv H Tunheim; Philippe Collas; Jan E Brinchmann
Journal:  Mol Biol Cell       Date:  2005-01-05       Impact factor: 4.138

Review 3.  Perspectives on RUNX genes: an update.

Authors:  M Michael Cohen
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

Review 4.  Runx family genes, niche, and stem cell quiescence.

Authors:  Chelsia Qiuxia Wang; Bindya Jacob; Giselle Sek Suan Nah; Motomi Osato
Journal:  Blood Cells Mol Dis       Date:  2010-02-09       Impact factor: 3.039

Review 5.  Decay-accelerating factor (CD55): a versatile acting molecule in human malignancies.

Authors:  Jan-Henrik Mikesch; Horst Buerger; Ronald Simon; Burkhard Brandt
Journal:  Biochim Biophys Acta       Date:  2006-05-09

6.  Runx2 in normal tissues and cancer cells: A developing story.

Authors:  Karen Blyth; Francois Vaillant; Alma Jenkins; Laura McDonald; Marie Anne Pringle; Camille Huser; Torsten Stein; James Neil; Ewan R Cameron
Journal:  Blood Cells Mol Dis       Date:  2010-06-26       Impact factor: 3.039

7.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

8.  RUNX3 copy number predicts the development of UC-associated colorectal cancer.

Authors:  Toshiaki Watanabe; Takashi Kobunai; Hiroki Ikeuchi; Yoko Yamamoto; Keiji Matsuda; Soichiro Ishihara; Keijiro Nozawa; Hisae Iinuma; Takamitsu Kanazawa; Toshiaki Tanaka; Tadashi Yokoyama; Tsuyoshi Konishi; Kiyoshi Eshima; Yoichi Ajioka; Toshifumi Hibi; Mamoru Watanabe; Tetsuichiro Muto; Hirokazu Nagawa
Journal:  Int J Oncol       Date:  2011-01       Impact factor: 5.650

9.  Gene expression profiling of pediatric acute myelogenous leukemia.

Authors:  Mary E Ross; Rami Mahfouz; Mihaela Onciu; Hsi-Che Liu; Xiaodong Zhou; Guangchun Song; Sheila A Shurtleff; Stanley Pounds; Cheng Cheng; Jing Ma; Raul C Ribeiro; Jeffrey E Rubnitz; Kevin Girtman; W Kent Williams; Susana C Raimondi; Der-Cherng Liang; Lee-Yung Shih; Ching-Hon Pui; James R Downing
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

10.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

View more
  26 in total

Review 1.  Posttranslational modifications of RUNX1 as potential anticancer targets.

Authors:  S Goyama; G Huang; M Kurokawa; J C Mulloy
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

2.  CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Authors:  B L N Than; J F Linnekamp; T K Starr; D A Largaespada; A Rod; Y Zhang; V Bruner; J Abrahante; A Schumann; T Luczak; A Niemczyk; M G O'Sullivan; J P Medema; R J A Fijneman; G A Meijer; E Van den Broek; C A Hodges; P M Scott; L Vermeulen; R T Cormier
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

3.  Nuclear FAK and Runx1 Cooperate to Regulate IGFBP3, Cell-Cycle Progression, and Tumor Growth.

Authors:  Marta Canel; Adam Byron; Andrew H Sims; Jessy Cartier; Hitesh Patel; Margaret C Frame; Valerie G Brunton; Bryan Serrels; Alan Serrels
Journal:  Cancer Res       Date:  2017-08-14       Impact factor: 12.701

Review 4.  The RUNX family: developmental regulators in cancer.

Authors:  Yoshiaki Ito; Suk-Chul Bae; Linda Shyue Huey Chuang
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

Review 5.  New insights into the role of Runx1 in epithelial stem cell biology and pathology.

Authors:  Cornelia Johanna Franziska Scheitz; Tudorita Tumbar
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

6.  The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.

Authors:  Mamadou Keita; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2013-02-26       Impact factor: 4.534

Review 7.  The RUNX family in breast cancer: relationships with estrogen signaling.

Authors:  N-O Chimge; B Frenkel
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

8.  Defining the Teratoma as a Model for Multi-lineage Human Development.

Authors:  Daniella McDonald; Yan Wu; Amir Dailamy; Justin Tat; Udit Parekh; Dongxin Zhao; Michael Hu; Ann Tipps; Kun Zhang; Prashant Mali
Journal:  Cell       Date:  2020-11-04       Impact factor: 41.582

9.  Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.

Authors:  Dmitry Voronov; Anastasia Gromova; Daren Liu; Driss Zoukhri; Alexander Medvinsky; Robyn Meech; Helen P Makarenkova
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

10.  CBFβ promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner.

Authors:  Chen Wang; Ziyu Shi; Yuqian Zhang; Mingyue Li; Jie Zhu; Zhen Huang; Junfeng Zhang; Jiangning Chen
Journal:  Cell Death Differ       Date:  2021-05-28       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.